Status:
UNKNOWN
Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this protocol is to study the prophylactic effect of remifentanil on bispectral index variation during a nociceptive stimuli.
Detailed Description
Pain is difficult to estimate in ICU because most of the patients are sedated. Bispectral index could be helpful in detecting this pain in ICU patients. Remifentanil is a morphinomimetic product with ...
Eligibility Criteria
Inclusion
- Sedated patient with mechanical ventilation with suspected nosocomial pneumonia
Exclusion
- Pace maker
- Neurologic illness
- Hemodynamic instability
- Hypothermia
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00162591
Start Date
October 1 2004
Last Update
November 22 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Surgical ICU Bichat Claude Bernard
Paris, France, 75018